PRE FI GENE MUTATION Flashcards

(55 cards)

1
Q
  • PERMANENT ALTERATION in the DNA sequence that makes up a gene
  • Causes: ERRORS IN DNA REPLICATION, EXPOSURE to various ENVIRONMENTAL FACTORS (radiation, chemicals, or certain viruses)
  • Wide range of effects: harmless, genetic disorders, development of diseases (cancer)
A

GENE MUTATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

TYPE OF MUTATION:
- substitution of 1 nucleotide, will NOT CHANGE the amino acid sequence

A

SILENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TYPE OF MUTATION:
- CHANGE the amino acid sequence, but the replacement & the original amino acid HAVE SIMILAR BIOCHEMICAL PROPERTIES

A

CONSERVATIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

TYPE OF MUTATION:
- replacement of amino acid w/ a BIOCHEMICALLY DIFFERENT AMINO ACID

A

NONCONSERVATIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TYPE OF MUTATION:
- terminates proteins prematurely when a nucleotide substitution produces a STOP CODON

A

NONSENSE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TYPE OF MUTATION:
- addition/deletion of nucleotides in a DNA sequence disrupts the READING FRAME

A

FRAMESHIFT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

purine replaces a purine or pyrimidine with a
pyrimidine.

A

TRANSITION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

purine replaces a pyrimidine or
pyrimidine replaces a purine.

A

TRANSVERSION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

 Used to DIRECTLY ANALYZE the CHANGE in protein structure of function.
 Other uses:
o Metabolic defects where several genes are
involved in the disease phenotype.
o Detection of the actual protein/ amino acid alterations.

A

BIOCHEMICAL METHODS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BIOCHEMICAL METHODS INLUDE

A
  1. Enzyme Immunoassays
  2. Immunohistochemistry
  3. High-performance liquid chromatography
    (HPLC)
  4. Gas chromatography
  5. Mass spectrometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

 Detects the PRESENCE OF METABOLITES in the blood, urine, or other biological fluids.
 Involve the USE OF SPECIFIC ANTIBODIES or other ligands to detect the presence of the target molecules.
- useful in the detection of antibodies against infectious agents
- Antibody specific for the target analyte is immobilized in plate wells. If present, antigen binds to the antibody and is detected with a secondary antibody conjugated to enzyme (AP, alkaline phosphatase)

A

Enzyme Immunoassays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Widely used EIA (Enzyme Immunoassays)

A

enzyme-linked
immunosorbent assay (ELISA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

 Longstanding method that allows DETECTION OF PROTEIN ABNORMALITIES on situ.
 Formalin-fixed paraffin-embedded tissue: <5 microns slices (microtome)
 Fixation can affect tissue antigens –> altering/covering some EPITOPES–> can be solved by antigen retrieval:
a. ENZYME DIGESTION (proteinase K, chymotrypsin, pepsin, pronase)
b. HEATING TISSUE SECTIONS IN WATER/BUFFER
 Snap frozen tissue (in isopentane, at -160C): 5 to 15-micron slices (cryostat inside of a chamber held at 20C)
 Fixation: acetone
 Sections are dried and stored frozen
 Rehydration of the dried sections in PHOSPHATE-BUFFERED SALINE

A

Immunohistochemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

To avoid the effects of formalin fixation, ____________________
may be used

A

snap frozen tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Substances such as ______, _________, or__________ in the tissue may interfere with IHC results

A
  • endogenous peroxidase
  • fluorescence
  • nonspecific antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

blocking solution with serum protein (albumin),
detergent (Tween 20), and unlabeled antibodies

PURPOSE?

A

TO MINIMIZE NONSPECIFIC BINDING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

included with samples to ensure the ADEQUACY and SPECIFICITY of staining.

A

POSITIVE AND NEGATIVE CONTROLS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Imaging/ microscopic observation of antibody
requires a signal from the antibody:
- fluorescent molecules
(fluorescein, Cy5, phycoerythrin)

A

FLUORESCENT SIGNAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Imaging/ microscopic observation of antibody
requires a signal from the antibody:
- substrate solution is
added, oxidized by the enzymes (horseradish peroxidase/

o Most frequently used: red/ brown IHC staining

A

COLORIMETRIC SIGNAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

 SEPARATION OF MOLECULES (nucleic acids and proteins) in solution through interaction with a solid support in the column.

A

High-performance liquid chromatography
(HPLC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

2 PHASES OF High-performance liquid chromatography
(HPLC)

A
  • MOBILE PHASE (SOLVENT)
  • STATIONARY PHASE (SOLID SUPPORT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

INCREASE RESOLUTION and LOWER SEPARATION TIME while using less solvent; faster flow rates (5mL/ min).

A

Ultra-HPLC (UHPLC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HPLC Types of detectors:

A
  • LIGHT SCATTERING
  • FLUORESCENCE
  • REFRACTIVE INDEX
  • UV LIGHT ABSORPTION
  • MASS SPECTROMETRY
24
Q
  • SEPARATION OF VAPORIZED SAMPLE through a column of inert carrier gas (mobile phase) & liquid (stationary phase)
  • used for DETECTION OF DRUGS & POISONS & their metabolites in biological samples
  • may be COUPLE W/ MS to detect BIOMARKERS OF DISEASE
A

Gas chromatography

25
Gas chromatography DETECTOR?
FLAME IONIZATION DETECTOR
26
- CONVERTS MOLECULES TO ION that can be moved in a magnetic field based on their CHARGE and MASS. - Readout: spectrum with mass/ charge value on the x-axis and abundance of the ion on the y-axis  ID of molecule: by their characteristic spectrum/ set of peaks
Mass spectrometry
27
Mass spectrometry 2 ionization methods for large biomolecules (proteins): - test sample is converted into a FINE SPRAY OF CHARGED DROPLETS that are electrostatically directed to the mass spectrometer inlet - MULTIPLE IONIZED SPECIES FROM ONE PROTEIN are separated by mass and charge. - results are plotted as mass/charge ratio (m/z) and relative abundance
Electrospray ionization (ESI)
28
Mass spectrometry 2 ionization methods for large biomolecules (proteins): - produces ions by firing a laser pulse into the sample coated with a matrix (organic compound) - sample is adhered to the matrix on a sample plate, ionized (protonated)
Matrix-assisted laser desorption/ ionization (MALDI)
29
MS: - high MW molecules - ionized molecules are accelerated at a fixed point & allowed to drift through the flight tube to the detector
MALDI - TOF (time-of-flight) spectrometer
30
MS: - combined w/ TOF - offers flexibility in the ID & quantification of properties
Surface - enhanced laser desorption/ionization (SELDI)
31
 Performed on a variety of specimen types: blood or buccal cells.  DNA mutations from single-base pair changes to large chromosomal rearrangements can be detected.
NUCLEIC ACID ANALYSES
32
simplified mutation detection (limiting specimens).
PCR amplification
33
most definitive method for detecting mutations.
DNA sequencing
34
Hybridization-based Methods
a. Single-Strand Conformation Polymorphism (SSCP) b. Allele-Specific Oligomer Hybridization (ASO) c. Melt-Curve Analysis (MCA) d. Heteroduplex Analysis e. Array Technology
35
Hybridization-based Methods:  Based on the PREFERENCE OF DNA to EXIST in a double-stranded state.  ABSENCE OF THE COMPLEMENTARY STRAND: nucleic acids form intrastrand duplexes, 3D structure (conformer). o Shape: kinks, loops, bubbles, tail  Bands/peaks pattern - different from the normal sequence (control) conformers --> presence of gene mutation - detected by SILVER STAIN, RADIOACTIVITY, or FLUORESCENCE a. Melt-Curve Analysis (MCA) b. Heteroduplex Analysis c. Single-Strand Conformation Polymorphism (SSCP) d. Array Technology e. Allele-Specific Oligomer Hybridization (ASO)
c. Single-Strand Conformation
36
Hybridization-based Methods:  Utilizes DIFFERENCES in the Tm OF SHORT SEQUENCES (20 bases) with 1 or 2 mismatches and those with no mismatches.  SYNTHETIC SS-PROBES (labeled) with normal/ mutant target DNA sequence (immobilized) in a solution.  At specific annealing temperatures and conditions (STRINGENCY) a. Probe will not bind to a near complementary target sequences with 1 or 2 mismatched bases b. Probe with perfect complementary sequence will bind a. Melt-Curve Analysis (MCA) b. Heteroduplex Analysis c. Single-Strand Conformation Polymorphism (SSCP) d. Array Technology e. Allele-Specific Oligomer Hybridization (ASO)
Allele-Specific Oligomer Hybridization (ASO)
37
Allele-Specific Oligomer Hybridization (ASO)  Bound probes will be detected with a conjugated _______________ and will be exposed to a CHROMOGENIC/CHEMILUMINESCENT SUBSTRATE generating a COLOR/ LIGHT SIGNAL indicating the binding of the test DNA to the probe.
horseradish peroxidase- anti biotin Fab fragment
38
Hybridization-based Methods:  Method of analyzing the DISSOCIATION OF ds-DNA during the HEATING CYCLES  PCR amplicons in the presence of a DNA specific fluorescent dye (EtBr, SYBR green, LC green) are heated (0.3C/ sec).  Rise in the temperature, DNA duplexes begin to separate into single strands, losing the dye.  Black line --> targets with different mismatches to the hybridization probe.  Sequence differences result in different melting characteristics and Tm for each sequences.  Interpretation of results by the temperature peak placement with respect to the temperature on the x-axis a. Melt-Curve Analysis (MCA) b. Heteroduplex Analysis c. Single-Strand Conformation Polymorphism (SSCP) d. Array Technology e. Allele-Specific Oligomer Hybridization (ASO)
Melt-Curve Analysis (MCA)
39
Melt-Curve Analysis (MCA) - overlaying peaks at expected Tm
Specimen with identical sequences
40
Melt-Curve Analysis (MCA) – 2 or more peaks at different temperatures
Specimen with different sequences
41
Hybridization-based Methods:  Formed when single strands that are NOT COMPLETELY COMPLEMENTARY HYBRIDIZE TO ONE ANOTHER  Can be resolved through POLYACRYLAMIDE/ AGAROSE GEL ELECTROPHORESIS: presence of bands different from a homozygous reference control is indicative of mutation.  Can also be resolved in denaturing high- performance liquid chromatography (DHPLC). a. Melt-Curve Analysis (MCA) b. Heteroduplex Analysis c. Single-Strand Conformation Polymorphism (SSCP) d. Array Technology e. Allele-Specific Oligomer Hybridization (ASO)
Heteroduplex Analysis
42
Hybridization-based Methods: - HIGH DENSITY OLIGONUCLEOTIDE ARRAYS: test DNA is fragmented by treatment with DNase before binding to the complementary probes on the array. a. Melt-Curve Analysis (MCA) b. Heteroduplex Analysis c. Single-Strand Conformation Polymorphism (SSCP) d. Array Technology e. Allele-Specific Oligomer Hybridization (ASO)
Array Technology
43
Array Technology Hybridization formats: – base substitution is always in the 12th position from the 3’ end of the probe.
Standard tiling
44
Array Technology Hybridization formats: – same mutation ID placed at different positions in the probe.
Redundant tiling
45
Array Technology Hybridization formats: – uses sets of color- coded polystyrene beads in suspension as the solid matrix.
Bead array technology
46
Sequence (polymerization) - Based Methods - DETECT POINT MUTATIONS & other SNPS - Primer 3’ end falls on the nucleotide to be analyzed o Must match the template perfectly to be extended by Taq polymerase. o Presence/ absence of the product = presence/ absence of the mutation. a. Sequence-Specific (Primer) PCR (SSP- PCR) b. Allelic Discrimination with Fluorogenic Probes
Sequence-Specific (Primer) PCR (SSP- PCR)
47
Sequence (polymerization) - Based Methods  Thermal cyclers with fluorescent detection.  RT-PCT, using 2 PROBES labeled 3’ quencher molecules and different fluors on the 5’ ends (complementary to either normal/ mutant sequence).  Prescence of corresponding fluorescent signal indicates whether the test sequences is normal/ mutant. a. Sequence-Specific (Primer) PCR (SSP- PCR) b. Allelic Discrimination with Fluorogenic Probes
Allelic Discrimination with Fluorogenic Probe
48
Enzymatic/ chemical Cleavage Methods:  Can detect sequence alterations  Mutand changes the structure of a restriction enzyme target site/ changes the size of a fragment.  PCR-RFLR is used A. Nonisotopic RNase Cleavage Assay (NIRCA) B. Cleavage Assay C. Restriction Fragment Length Polymorphisms (RFLPs)
Restriction Fragment Length Polymorphisms (RFLPs)
49
Enzymatic/ chemical Cleavage Methods:  Heteroduplex analysis using duplex RNA  T7 or SP6 phage RNA polymerase  Detection mutation: heteroduplexes form between normal and mutant transcripts  targets for cleavage by RNase enzymes (E. coli RNaw and Aspergillus RNase T1)  Remaining dsRNA fragments can then be separated by agarose gel electrophoresis. A. Nonisotopic RNase Cleavage Assay (NIRCA) B. Cleavage Assay C. Restriction Fragment Length Polymorphisms (RFLPs)
Nonisotopic RNase Cleavage Assay (NIRCA)
50
Enzymatic/ chemical Cleavage Methods:  Bases on the characteristic enzymatic activity of CLEAVASE .  Premixed reagents (including cleavase) + standard 96 well-plate + test specimens + controls  Clevaase: recognizes the structure formed by hybridization of the normal/ mutant probes to the test sequences  If the probe and test reactions occur --> fluorescent signal (standard fluorometer) A. Nonisotopic RNase Cleavage Assay (NIRCA) B. Cleavage Assay C. Restriction Fragment Length Polymorphisms (RFLPs)
Cleavage Assay
51
provide specific multiplex detection and sensitivity required for clinical applications.
Array-based methods and massive parallel sequencing methods
52
Method selected will depend on the _________________, ______________, and the _____________
- available instrumentation - genetic target - nature of mutation
53
Descriptive and consistent system of expressing mutations/ polymorphisms.
GENE VARIANT NOMENCLATURE
54
Indicated by: o Position of the mutation in the genomic sequence of the DNA/ position from the end of the coding sequence (exons) + position in the intron
INTRONS OF GENOMIC DNA
55
- Set by the Human Genome Organization (HUGO) gene nomenclature committee - should be capitalized and set in italics with no hyphens
GENE NAMES